Please login to the form below

Not currently logged in
Email:
Password:

Ovid Therapeutics

This page shows the latest Ovid Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Biotech leaders jump into US free speech debate

Biotech leaders jump into US free speech debate

Alnylam chief executive John Maraganore, Decibel Therapeutics’ CEO Steve Holtzman, Acorda CEO Ron Cohen and Jeremy Levin of Ovid Therapeutics are the main signatories to the letter published In Nature, but

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Ovid Therapeutics adds member to scientific advisory board Ovid Therapeutics adds member to scientific advisory board

    Dr Jerome Zeldis joins the firm. New York-based Ovid Therapeutics has appointed Dr Jerome Zeldis to its scientific advisory board. ... He said: “Ovid is pursuing an ambitious approach of tackling rare neurological diseases with significant unmet needs.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics